Soleno Therapeutics Ownership | Who Owns Soleno Therapeutics?

Soleno Therapeutics Ownership Summary

Soleno Therapeutics is owned by 16.52% institutional investors, 3.12% insiders, and 80.36% retail investors. Vivo capital is the largest institutional shareholder, holding 15.02% of SLNO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.46% of its assets in Soleno Therapeutics shares.

SLNO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Soleno Therapeutics	16.52%	3.12%	80.36%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vivo capital	6.29M	15.02%	$282.82M
Janus henderson group	5.19M	12.39%	$233.13M
Nantahala capital management	3.93M	9.38%	$176.61M
Adage capital partners gp	2.78M	6.63%	$124.78M
Avoro capital advisors	2.52M	6.03%	$113.50M
Blackrock	1.86M	5.15%	$76.03M
Blackrock funding, inc. /de	2.01M	4.80%	$90.34M
Vanguard group	1.88M	4.50%	$84.71M
Price t rowe associates inc /md/	1.63M	3.89%	$73.30M
Commodore capital lp	1.52M	3.64%	$68.55M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Vivo capital	6.29M	31.68%	$282.82M
Artia global partners lp	494.42K	7.94%	$22.22M
Nantahala capital management	3.93M	7.58%	$176.61M
Commodore capital lp	1.52M	5.02%	$68.55M
Ghost tree capital	300.00K	3.83%	$12.24M
Ally bridge group (ny)	87.63K	3.38%	$3.94M
Altium capital management lp	250.00K	3.19%	$11.24M
Nan fung group	79.65K	3.06%	$3.58M
Vestal point capital, lp	1.06M	2.82%	$47.65M
Exome asset management	77.28K	2.61%	$3.47M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.86M	0.00%	1.54M
Janus henderson group	5.19M	0.12%	1.11M
Nantahala capital management	3.93M	7.58%	658.52K
Westfield capital management co lp	881.46K	0.17%	385.75K
Holocene advisors, lp	955.47K	0.14%	361.10K

Top Sellers

Holder	Shares	% Assets	Change
Carlyle group	1.38M	1.49%	-2.70M
Perceptive advisors	1.50M	1.86%	-1.70M
Assenagon asset management	-	-	-729.84K
Alyeska investment group	424.08K	0.07%	-552.02K
Adage capital partners gp	2.78M	0.22%	-546.17K

New Positions

Holder	Shares	% Assets	Change	Value
Siren	351.82K	0.70%	351.82K	$15.81M
Logos global management lp	350.00K	1.84%	350.00K	$15.73M
Timessquare capital management	339.77K	0.22%	339.77K	$15.27M
Pfm health sciences, lp	307.50K	0.86%	307.50K	$13.82M
Rock springs capital management lp	124.09K	0.21%	124.09K	$5.58M

Sold Out

Holder	Change
National bank of canada /fi/	-1.00
Harbour investments	-5.00
Smartleaf asset management	-9.00
Russell investments group	-11.00
Capital performance advisors llp	-17.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	49	-68.59%	6,917,396	-85.32%	16	0.13%	35	-66.02%	6	-75.00%
Sep 30, 2024	156	31.09%	47,121,280	8.78%	112	0.79%	103	30.38%	24	-4.00%
Jun 30, 2024	119	10.19%	43,316,980	21.90%	119	1.24%	79	3.95%	25	66.67%
Mar 31, 2024	108	28.57%	35,536,015	13.14%	98	1.18%	76	35.71%	15	15.38%
Dec 31, 2023	84	55.56%	31,409,972	54.72%	91	2.62%	56	33.33%	13	62.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.13M	2.46%	-
Janus Henderson Global Life Sciences	933.30K	2.16%	293.68K
Janus Henderson Global Life Sciences D	932.52K	2.03%	-776.00
Vanguard US Total Market Shares ETF	913.59K	1.99%	-
Janus Global Life Science AUSD	738.87K	1.71%	262.71K
Janus Henderson Glb Life Scn I2 USD	750.80K	1.64%	-923.00
iShares Russell 2000 ETF	673.99K	1.47%	-5.83K
SPDR® S&P Biotech ETF	567.89K	1.24%	-6.08K
Janus Henderson US SMID Cap Growth	457.55K	1.06%	-9.40K
Janus Henderson US SMID Cap Growth MA	457.55K	1.06%	457.52K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 01, 2025	Hirano Patricia C	SEE REMARKS	Sell	$265.16K
Mar 28, 2025	Pauls Matthew	-	Sell	$424.80K
Mar 27, 2025	Yen Kristen	SEE REMARKS	Sell	$116.70K
Mar 27, 2025	Yen Kristen	SEE REMARKS	Sell	$192.43K
Mar 27, 2025	Yen Kristen	SEE REMARKS	Sell	$354.68K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	1
2025 Q1	-	83
2024 Q4	-	8
2024 Q3	-	47
2024 Q2	-	10

SLNO Ownership FAQ

Who Owns Soleno Therapeutics?

Soleno Therapeutics shareholders are primarily institutional investors at 16.52%, followed by 3.12% insiders and 80.36% retail investors. The average institutional ownership in Soleno Therapeutics's industry, Biotech Stocks , is 68.48%, which Soleno Therapeutics falls below.

Who owns the most shares of Soleno Therapeutics?

Soleno Therapeutics’s largest shareholders are Vivo capital (6.29M shares, 15.02%), Janus henderson group (5.19M shares, 12.39%), and Nantahala capital management (3.93M shares, 9.38%). Together, they hold 36.79% of Soleno Therapeutics’s total shares outstanding.

Does Blackrock own Soleno Therapeutics?

Yes, BlackRock owns 5.15% of Soleno Therapeutics, totaling 1.86M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 76.03M$. In the last quarter, BlackRock increased its holdings by 1.54M shares, a 471.09% change.

Who is Soleno Therapeutics’s biggest shareholder by percentage of total assets invested?

Vivo capital is Soleno Therapeutics’s biggest shareholder by percentage of total assets invested, with 31.68% of its assets in 6.29M Soleno Therapeutics shares, valued at 282.82M$.

Who is the top mutual fund holder of Soleno Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Soleno Therapeutics shares, with 2.46% of its total shares outstanding invested in 1.13M Soleno Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools